Capital Fund Management S.A. purchased a new stake in shares of Schrodinger, Inc. (NASDAQ:SDGR – Free Report) during the 2nd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund purchased 73,838 shares of the company’s stock, valued at approximately $1,486,000. Capital Fund Management S.A. owned 0.10% of Schrodinger at the end of the most recent quarter.
A number of other institutional investors have also recently bought and sold shares of the business. PNC Financial Services Group Inc. increased its holdings in shares of Schrodinger by 29.9% in the 1st quarter. PNC Financial Services Group Inc. now owns 2,956 shares of the company’s stock valued at $58,000 after purchasing an additional 680 shares during the period. Bank of Montreal Can grew its position in Schrodinger by 5.8% during the second quarter. Bank of Montreal Can now owns 15,941 shares of the company’s stock valued at $321,000 after purchasing an additional 879 shares in the last quarter. Farther Finance Advisors LLC increased its stake in Schrodinger by 347.4% in the 2nd quarter. Farther Finance Advisors LLC now owns 1,284 shares of the company’s stock valued at $26,000 after buying an additional 997 shares during the period. Commonwealth of Pennsylvania Public School Empls Retrmt SYS lifted its position in Schrodinger by 8.2% in the 2nd quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS now owns 14,343 shares of the company’s stock worth $289,000 after buying an additional 1,082 shares in the last quarter. Finally, MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. boosted its stake in shares of Schrodinger by 4.5% during the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 33,055 shares of the company’s stock valued at $653,000 after buying an additional 1,412 shares during the period. 79.05% of the stock is currently owned by institutional investors and hedge funds.
Schrodinger Stock Performance
SDGR opened at $18.42 on Friday. The firm has a market cap of $1.36 billion, a P/E ratio of -7.64 and a beta of 1.56. The business has a 50 day moving average price of $19.32 and a 200 day moving average price of $20.25. Schrodinger, Inc. has a twelve month low of $15.99 and a twelve month high of $28.47.
Analysts Set New Price Targets
A number of equities analysts have recently weighed in on SDGR shares. Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Schrodinger in a research note on Tuesday, October 14th. Wall Street Zen raised Schrodinger from a “sell” rating to a “hold” rating in a research report on Saturday, October 25th. The Goldman Sachs Group initiated coverage on Schrodinger in a report on Monday, September 29th. They set a “neutral” rating and a $19.00 price target for the company. Barclays initiated coverage on Schrodinger in a report on Thursday, August 14th. They issued an “overweight” rating and a $25.00 price objective on the stock. Finally, Citigroup cut shares of Schrodinger from a “buy” rating to a “neutral” rating and reduced their target price for the company from $35.00 to $20.00 in a research note on Friday, August 15th. Three analysts have rated the stock with a Buy rating, three have given a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat, the company currently has a consensus rating of “Hold” and an average price target of $26.00.
View Our Latest Report on Schrodinger
Insider Buying and Selling
In other Schrodinger news, insider Margaret Dugan sold 1,395 shares of the business’s stock in a transaction on Thursday, October 16th. The shares were sold at an average price of $21.07, for a total transaction of $29,392.65. Following the completion of the transaction, the insider owned 24,574 shares of the company’s stock, valued at $517,774.18. The trade was a 5.37% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. 21.00% of the stock is owned by company insiders.
About Schrodinger
Schrödinger, Inc, together with its subsidiaries, develops physics-based computational platform that enables discovery of novel molecules for drug development and materials applications. The company operates in two segments, Software and Drug Discovery. The Software segment is focused on licensing its software to transform molecular discovery for life sciences and materials science industries.
Recommended Stories
- Five stocks we like better than Schrodinger
- Buy P&G Now, Before It Sets A New All-Time High
- The Trade Desk: After a 70% Plunge, This Could Be The Time to Buy
- Why Invest in High-Yield Dividend Stocks?
- Tap Into 2026 AI Infrastructure Gains With This High-Growth ETF
- Retail Stocks Investing, Explained
- Strong Quarter, Weak Reaction: Why GitLab Shares Dropped
Want to see what other hedge funds are holding SDGR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Schrodinger, Inc. (NASDAQ:SDGR – Free Report).
Receive News & Ratings for Schrodinger Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Schrodinger and related companies with MarketBeat.com's FREE daily email newsletter.
